Physician

Benjamin Lev Solomon, M.D.

According to 2025 Medicare claims, Benjamin Solomon, M.D. (NPI: 1518209485) practices hematology/oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84088-8858.

Solomon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 222 traditional Medicare patients, billed 77,457 HCPCS/CPT codes, and received $1,435,085 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 881 prescription claims across 160 beneficiaries totaling $2,567,787 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 64 claims. Open Payments data shows 46 records totaling $917. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $8,842 to $1,435,085. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,964 to $2,567,787. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	71	116	$8,842
2020	176	562	$36,580
2021	179	630	$57,230
2022	175	590	$53,388
2023	231	42,456	$562,391
2024	222	77,457	$1,435,085

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	66	216	$26,964
2016	65	173	$9,298
2017	32	64	$5,002
2018	25	40	$955
2019	36	130	$11,135
2020	66	315	$89,270
2021	76	431	$415,745
2022	104	579	$276,753
2023	142	482	$808,716
2024	160	881	$2,567,787

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	22	54	$6,779
2021	N/R	85	$6,673
2022	N/R	64	$2,217
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	243	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	105	191	$63
82728	Ferritin (blood protein) level	57	105	$13
80053	Blood test, comprehensive group of blood chemicals	165	522	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	176	588	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	71	2,014	$1,138,400
Calquence	Acalabrutinib Maleate	25	750	$364,533
Ibrance	Palbociclib	21	672	$194,527
Kisqali	Ribociclib Succinate	18	504	$181,260
Brukinsa	Zanubrutinib	13	390	$176,852

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$917	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Lev Solomon, M.D.?

Tedicare shows public-source Medicare data for Benjamin Lev Solomon, M.D. (NPI 1518209485), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Lev Solomon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin Lev Solomon, M.D.?

Benjamin Lev Solomon, M.D. is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Benjamin Lev Solomon, M.D. have Open Payments data?

Benjamin Lev Solomon, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.